Monodes(N-carboxymethyl)valine Daclatasvir is primarily used in the pharmaceutical industry as an intermediate in the synthesis of Daclatasvir, an antiviral medication. Daclatasvir is a key component in the treatment of chronic hepatitis C virus (HCV) infection, particularly genotypes 1 and 3. It functions as a NS5A inhibitor, effectively blocking the replication of the virus. This chemical plays a crucial role in ensuring the high purity and efficacy of the final drug product, contributing to improved therapeutic outcomes for patients with HCV. Its application is vital in the production of antiviral therapies, aiding in the global effort to combat hepatitis C.